enGene Therapeutics Inc. financial statements
enGene Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 117.3M | 10-K |
| Cash and equivalents | USD 50.15M | 10-Q |
enGene Therapeutics Inc. financials on 6ix · enGene Therapeutics Inc. on 6ix